Joe Wiley, Amryt Pharma CEO
January 8, 2023 06:10 PM EST
Deals
Pharma

#JPM23 kicks off with an ac­qui­si­tion as Chiesi inks all-cash $1B+ deal for Am­ryt

Kyle LaHucik

Senior Reporter

As many of the in­dus­try’s big­wigs ar­rive in the Bay Area to hash out deals, Chiesi Far­ma­ceu­ti­ci is show­ing up with an all-cash ac­qui­si­tion in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times